Orchid Island Capital (ORC) reported robust fourth-quarter earnings, driven by a stable interest rate environment, tightening mortgage spreads, and lower funding costs. The REIT continued its strategic pivot into higher-coupon mortgage pools with built-in prepayment protection.
Hilltop Holdings capped off 2025 with a 46% surge in net income, fueled by a steeper yield curve and disciplined cost management across its banking and securities units. While the mortgage division remains under pressure, executives point to a robust loan pipeline and shareholder returns as signs of resilience heading into 2026.
Novo Nordisk's newly launched oral GLP-1 drug, amycretin, has seen explosive initial demand in the U.S., potentially setting the stage for a significant financial turnaround and stock rally after a challenging previous year.
Following its strategic rebrand from Barrick Gold, Barrick Mining (B) has delivered staggering shareholder returns, reigniting investor interest. Yet, with shares trading at a premium to some fair value estimates, analysts are questioning whether the market has gotten ahead of itself.
As SpaceX nears a deal to acquire xAI, analysts see a straightforward step in Elon Musk's grand vision. However, integrating the publicly traded Tesla into a sprawling 'Musk Inc.' conglomerate presents a far more complex financial and regulatory challenge for investors.
After a volatile debut, Figma's stock presents a classic growth investing dilemma. Bulls point to its rapid user adoption and potential to reshape digital design, while its lofty valuation demands flawless execution in a competitive market.
Once a high-flying cloud communications leader, Five9 now trades at distressed valuations. With new leadership, activist investors circling, and a deep enterprise footprint, bulls see a prime candidate for a strategic rerating or acquisition.
Despite political pressure and vast reserves, U.S. oil majors ExxonMobil and Chevron are taking a cautious stance on new spending in Venezuela, demanding legal stability and fiscal reforms before committing fresh capital, even as they signal long-term interest.
Toyota Motor posts record annual sales of 10.5 million vehicles, solidifying its global leadership. As its shares show strong long-term gains, investors are weighing future growth potential against tariff pressures and valuation concerns.
Shares of the alternative asset manager have retreated sharply from recent highs, prompting investors to question whether the stock's premium valuation remains justified. We examine the key metrics and what the pullback might signal.
Despite reporting stronger annual profits and lower charge-offs, LendingClub's stock faces significant pressure following its shift to fair value accounting and the launch of new growth initiatives like home improvement loans.
After a brutal 52.7% share price decline over the past year, GoDaddy (NYSE: GDDY) is trading near multi-year lows. We analyze whether the sell-off has created a deep-value opportunity for investors or if fundamental challenges justify the market's pessimism.
Amid soaring market expectations, ServiceNow is aggressively integrating AI across its platform through enhanced partnerships and strategic acquisitions, aiming to make artificial intelligence a native component of enterprise service and security operations.
Stryker Corporation's latest earnings report, driven by its MedSurg, Neurotechnology divisions and the Mako surgical robot, has reignited investor debate. With shares near $370 and a bullish fair value estimate of $427, analysts are weighing robust growth against a premium valuation.
As Tilray Brands' stock languishes near multi-year lows, a deep dive into its valuation metrics suggests a significant discount. But with the cannabis sector facing headwinds, is this a genuine opportunity for investors, or a sign of deeper troubles?
Shares of Pathward Financial (NASDAQ: CASH) have surged over 25% year-to-date, prompting investors to question whether the rally has left the stock overvalued. We examine the numbers behind two key valuation frameworks to assess if there's still room for growth.
Merck & Co. shifts its cancer drug development playbook, opting for targeted collaborations with Guardant Health and Eikon Therapeutics after walking away from a major acquisition. Analysts debate whether the stock's current price fully reflects its long-term pipeline potential.
Shares of Sterling Infrastructure have soared over 150% in the past year, fueled by its central role in U.S. infrastructure projects. As the stock hovers near $358, analysts and investors are debating whether the rally has run its course or if there's still room to grow.
Tetra Tech's stock has surged following strong Q1 results, raised guidance, and enhanced capital returns. While analysts see further upside, questions linger over contract risks and a premium valuation.
Viasat shares have rocketed 31% in a month, reigniting investor debate over whether the satellite communications firm is a hidden gem or a momentum-driven play facing stiff competition from SpaceX's Starlink and Amazon's Project Kuiper.
